Abiomed, Inc.ABMDNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P23
Within normal range
vs 2Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2022 | -12.20% |
| Q2 2022 | 1.61% |
| Q1 2022 | 0.68% |
| Q4 2021 | 6.83% |
| Q3 2021 | 222.63% |
| Q2 2021 | -178.47% |
| Q1 2021 | -11.98% |
| Q4 2020 | 16.33% |
| Q3 2020 | 80.05% |
| Q2 2020 | -41.32% |
| Q1 2020 | -17.37% |
| Q4 2019 | 16.74% |
| Q3 2019 | -0.89% |
| Q2 2019 | -7.13% |
| Q1 2019 | 4.86% |
| Q4 2018 | 23.92% |
| Q3 2018 | 7.64% |
| Q2 2018 | -1.72% |
| Q1 2018 | 6.26% |
| Q4 2017 | 41.10% |
| Q3 2017 | -4.09% |
| Q2 2017 | 14.09% |
| Q1 2017 | 14.14% |
| Q4 2016 | 75.10% |
| Q3 2016 | -31.67% |
| Q2 2016 | 7.17% |
| Q1 2016 | 13.59% |
| Q4 2015 | 36.09% |
| Q3 2015 | -14.73% |
| Q2 2015 | 21.58% |
| Q1 2015 | -9.51% |
| Q4 2014 | 227.02% |
| Q3 2014 | 371.65% |
| Q2 2014 | -141.82% |
| Q1 2014 | -19.94% |
| Q4 2013 | 228.61% |
| Q3 2013 | 206.96% |
| Q2 2013 | -131.63% |
| Q1 2013 | 1375.31% |
| Q4 2012 | -105.46% |